In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1729 News Items found
In the Lab
Geneticist Michael Berger
How Do Inherited Gene Mutations Cause Cancer? A New Database Will Help Researchers Find Out

In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations.
Pamela R. Drullinsky
MSK Breast Cancer Expert Shares Tips for Women with Telemundo Audience

MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.
Feature
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response

Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Man in surgical scrubs looks at reader
True Grit: One Man’s Incredible Journey To Become a Doctor at MSK

Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs

By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center Named in Fast Company’s First Annual List of “Brands That Matter”

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
New Finding Could Predict Which People with Lung Cancer Will Benefit from Chemotherapy

Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
Announcement
Promising PhD Students Awarded Funding to Support Doctoral Research at Gerstner Sloan Kettering

“We could not be more proud of this deserving group of the outstanding GSK students who have been recognized with fellowship support this academic year,” says GSK Dean Michael Overholtzer.